
News|Articles|July 1, 2002
Market share shift analysis identifies potential impact of atypical antipsychotic formulary addition on budget
Anoka Regional Treatment Facility, Anoka, MN-This 150-bed regional treatment facility was spending over half its annual budget on atypical antipsychotic medications. In an effort to better control rising drug class costs, a market share shift analysis of the products currently in use at the facility was conducted.
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Drug Pricing Not Main Driver of State Medicaid Spending | AMCP Nexus 2025
2
AI Helps Managed Care Identify High-Risk Patients Sooner and More Precisely | AMCP Nexus 2025
3
Real-World Study Shows $330,000 Cost Difference Between CAR T and BiTE Therapies | AMCP Nexus 2025
4
All In on AI for Efficiency, But Not For Clinical Judgment| AMCP Nexus 2025
5



















































